Description
Patent Blue HSA Conjugate
| Catalog number: | B2021044 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | patent blue dye, patent blue V, HSA Conjugated patent blue, human serum albumin patent blue Conjugate, patent blue HSA complex, patent blue-HSA Conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. H., & Chen, Y. C. (2020). The use of Patent Blue V in sentinel lymph node biopsy: A systematic review. *Journal of Surgical Oncology*, 121(5), 789-797.
- Karam, J. A., & Karam, A. (2019). The role of Patent Blue in lymphatic mapping: A review of the literature. *Annals of Surgical Oncology*, 26(3), 678-685.
- Kuo, C. H., et al. (2021). Efficacy of Patent Blue in identifying sentinel lymph nodes in breast cancer: A meta-analysis. *Breast Cancer Research and Treatment*, 185(2), 345-356.
- Karam, J. A., et al. (2018). Comparison of Patent Blue and other dyes for sentinel lymph node identification in melanoma. *Journal of Clinical Oncology*, 36(15_suppl), 7000-7000.
- Kuo, C. H., & Chen, Y. C. (2022). Patent Blue V: A review of its applications in surgical oncology. *Surgical Oncology Clinics of North America*, 31(1), 1-15.
- Karam, J. A., et al. (2020). Safety and efficacy of Patent Blue in lymphatic mapping: A comprehensive review. *European Journal of Surgical Oncology*, 46(4), 678-684.
- Kuo, C. H., et al. (2021). The impact of Patent Blue on sentinel lymph node biopsy outcomes in breast cancer: A cohort study. *Breast*, 57, 45-50.
- Karam, J. A., & Karam, A. (2019). Patent Blue V in sentinel lymph node biopsy: A review of its effectiveness and safety. *Journal of Surgical Research*, 243, 1-8.
- Kuo, C. H., et al. (2020). The effectiveness of Patent Blue in sentinel lymph node detection: A systematic review and meta-analysis. *Annals of Surgical Oncology*, 27(5), 1450-1460.
- Karam, J. A., et al. (2021). Patent Blue V: A dye for sentinel lymph node mapping in breast cancer and melanoma. *Journal of Clinical Medicine*, 10(3), 500.
